BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kansas Bioscience Authority Plans $26 Million for Research Initiatives in 2013


8/1/2012 8:08:10 AM

The board of directors for the Kansas Bioscience Authority has adopted an operating plan for the upcoming year that sets a target of investing more than $26 million in various research initiatives.

The plan is for fiscal year 2013, which started July 1.

To date, the KBA has invested $272 million in bioscience researchers and businesses. Wichita State University’s Center of Innovation for Biomaterials in Orthopaedic Research is among those recipients.

A KBA news release highlights some of the key points of the plan:

• Continued investment in the eminent scholar and rising star programs, which have predominantly served in the past to recruit key professionals to the University of Kansas Cancer Center to help KU gain the recently awarded National Cancer Institute designation.

• Investment in the new Biosecurity Research Attraction Program, which will support researchers at Kansas State University and elsewhere working to develop unique biosecurity research capabilities and facilities to address emerging animal health and public health threats.

• Further investment in expansion and attraction grants that add high-paying bioscience jobs and capital investment in Kansas. Previous such grants have produced one job for about every $10,000 invested, with the average annual wage for those jobs being nearly three-quarters more than the state’s annual average wage overall.

• Continued investment in the operations and programs of Heartland Plant Innovations, Manhattan, which is working to accelerate the discovery and commercialization of innovations that improve market performance of leading Kansas crops such as wheat and sorghum.

• $4 million available to help small Kansas bioscience companies through vouchers to support innovative research and development collaborations with other Kansas companies and universities and grants to support critical proof-of-concept projects and secure new federal funding.

• Support of the Life Sciences Manufacturing Initiative, a new program to address the lack of manufacturing capabilities in the medical device and drug sector that may limit the growth potential for the area’s life sciences. The complete 2013 operating plan is available online at www.kansasbioauthority.org/about-the-kba/aop/.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES